Fujimori Sangyo Co., Ltd

About Fujimori Sangyo Co., Ltd

Fujimori Sangyo CO., LTD. supplies materials, mainly plastic-related products, to customers in a variety of industries, including food, cosmetics, chemicals, and medical care.

We will meet a wide range of needs by proposing solutions to meet customer requirements, including plastic raw materials, final products, related machinery for using the products, and assembly work for commercialization.

Among them, we provide the medical and pharmaceutical industries with high quality packaging made in Japan.

  • JP
  • 2023
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Packaging & drug delivery
Packaging materials
Contact info
Meet us at

Pharmapack Europe 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025

Products from Fujimori Sangyo Co., Ltd (3)

  • High Clean Nested Prefilled Syringe's Packaging

    Product High Clean Nested Prefilled Syringe's Packaging

    We are manufacturing "High Clean Nested Prefilled Syringe's Packaging" in our factory. ・Headerbag ・Coated Lid ・Tyvek®Insert Nested syringe packaging is known to generate a lot of particles when opened. To prevent those particles from falling into the syringe, it is common to place a Tyvek®Insert in the n...
  • ■High Clean Nested Prefilled Syringe's Packaging

    Product ■High Clean Nested Prefilled Syringe's Packaging

    We are manufacturing "High Clean Nested Prefilled Syringe's Packaging" in our factory.

    ・Headerbag
    ・Coated Lid
    ・Tyvek®Insert

    Nested syringe packaging is known to generate a lot of particles when opened.
    To prevent those particles from falling into the syringe, it is common to place a ...
  • ■High Clean Sterilization Bag

    Product ■High Clean Sterilization Bag

    We manufacture the world's highest quality sterilization bags in Japan for high-quality medical device manufacturers in Japan and overseas.

    In the past, our clients had the following challenges・End-users (pharmaceutical companies, etc.) are increasingly demanding foreign material control, but th...